PMA device
Femsoft Urethral Insert
Rochester Medical Corp. · Transurethral Occlusion Insert, Urinary Incontinence-Control, Female (OCK, Class III) · First FDA decision Mar 21, 2013, newest Mar 21, 2013Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Femsoft Urethral"
MAUDE reports
0
Brand "Femsoft Urethral", since 2015
PubMed studies
0
Mentioning "Femsoft Urethral"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Femsoft Urethral Insert
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- FEMSOFT URETHRAL INSERTPMA supplement
P990002-S002 · Decided Mar 21, 2013 · 85 days after receipt · Normal 180 Day Track No User Fee
Device type: Transurethral occlusion insert, urinary incontinence-control, female (OCK) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Femsoft Urethral", any status and sponsor, newest update first.
No registered device study names "Femsoft Urethral".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Femsoft Urethral", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OCK
2 reports: 0 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1906-2010 · Started Apr 27, 2010 · Posted by FDA Jun 25, 2010
Reason given: Rochester Medical is voluntarily recalling specific lots of FemSoft urethral inserts manufactured and distributed in 2009 and 2010. Testing has revealed a small number of packages which contain a small void in the package seal, and it has been determined that product sterility cannot be guaranteed. If product...
Cause as FDA categorized it: Packaging · Device type: Transurethral Occlusion Insert, Urinary Incontinence-Control, Female (OCK)
Z-1907-2010 · Started Apr 27, 2010 · Posted by FDA Jun 25, 2010
Reason given: Rochester Medical is voluntarily recalling specific lots of FemSoft urethral inserts manufactured and distributed in 2009 and 2010. Testing has revealed a small number of packages which contain a small void in the package seal, and it has been determined that product sterility cannot be guaranteed. If product...
Cause as FDA categorized it: Packaging · Device type: Transurethral Occlusion Insert, Urinary Incontinence-Control, Female (OCK)
Z-1908-2010 · Started Apr 27, 2010 · Posted by FDA Jun 25, 2010
Reason given: Rochester Medical is voluntarily recalling specific lots of FemSoft urethral inserts manufactured and distributed in 2009 and 2010. Testing has revealed a small number of packages which contain a small void in the package seal, and it has been determined that product sterility cannot be guaranteed. If product...
Cause as FDA categorized it: Packaging · Device type: Transurethral Occlusion Insert, Urinary Incontinence-Control, Female (OCK)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Femsoft Urethral"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.